Why the study?
Ovarian hormones may contribute to lower stroke incidence in pre-menopausal women compared with men, but their role in cerebrovascular regulation remains unclear.
Does the menstrual cycle phase affect cerebral autoregulation in healthy eumenorrheic women?
Does the menstrual cycle phase affect cerebral autoregulation in healthy eumenorrheic women?
The menstrual cycle has limited impact on cerebrovascular autoregulation in healthy eumenorrheic women, suggesting that resting cerebrovascular function remains stable despite fluctuations in ovarian hormones.
Menstrual phase need not alter resting cerebral autoregulation evaluation in eumenorrheic women; leaves open estradiol's influence on regulation rate.
There is emerging evidence that ovarian hormones play a significant role in the lower stroke incidence observed in pre‐menopausal women compared with men. However, the role of ovarian hormones in cerebrovascular regulation remains to be elucidated. We examined the blood pressure‐cerebral blood flow relationship (cerebral autoregulation) across the menstrual cycle in eumenorrheic women ( n = 12; mean ± SD: age, 31 ± 7 years). Participants completed sit‐to‐stand and Valsalva maneuvers (VM, mouth pressure of 40 mmHg for 15 s) during the early follicular (EF), late follicular (LF), and mid‐luteal (ML) menstrual cycle phases, confirmed by serum measurement of progesterone and 17β‐estradiol. Middle cerebral artery blood velocity (MCAv), arterial blood pressure and partial pressure of end‐tidal carbon dioxide were measured. Cerebral autoregulation was assessed by transfer function analysis during spontaneous blood pressure oscillations, rate of regulation (RoR) during sit‐to‐stand maneuvers, and Tieck’s autoregulatory index during VM phases II and IV (AI‐II and AI‐IV, respectively). Resting mean MCAv (MCAv mean ), blood pressure, and cerebral autoregulation were unchanged across the menstrual cycle (all p > 0.12). RoR tended to be different (EF, 0.25 ± 0.06; LF; 0.19 ± 0.04; ML, 0.18 ± 0.12 sec −1 ; p = 0.07) and demonstrated a negative relationship with 17β‐estradiol (R 2 = 0.26, p = 0.02). No changes in AI‐II (EF, 1.95 ± 1.20; LF, 1.67 ± 0.77 and ML, 1.20 ± 0.55) or AI‐IV (EF, 1.35 ± 0.21; LF, 1.27 ± 0.26 and ML, 1.20 ± 0.2) were observed ( p = 0.25 and 0.37, respectively). Although, a significant interaction effect ( p = 0.02) was observed for the VM MCAv mean response. These data indicate that the menstrual cycle has limited impact on cerebrovascular autoregulation, but individual differences should be considered.
No takes yet. Share an insight, caveat, or question.
Korad et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: